research report      name index      key word index      corresp.unit            Page in german      Imprint + Privacy Policy   

Third-party-funded project

Performance of a clinical trial (Zevalin)

Project management at the University of Würzburg:

Participating scientists:

Labelling of Ibritumomab-Tiuxetan (Zevalin) for high dose therapy.

Key words:

Projekt period: from 03.2006 to 09.2006

Funding institution:
Wirtschaftsunternehmen ( Schering Deutschland GmbH ) ,Granting date: 22.03.2006